| Hans-Günter Meyer-Thompson | Methadon zur Substitution
The novel uncompetitive NMDA receptor antagonist esmethadone (REL-1017) has no meaningful abuse potential in recreational drug users.
The novel uncompetitive NMDA receptor antagonist esmethadone (REL-1017) has no meaningful abuse potential in recreational drug users.
Shram, M.J., Henningfield, J.E., Apseloff, G. et al.
Transl Psychiatry 13, 192 (2023). doi.org/10.1038/s41398-023-02473-8